Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,700 | 15 | 48.5% |
| Food and Beverage | $16,851 | 822 | 26.6% |
| Consulting Fee | $10,310 | 5 | 16.3% |
| Travel and Lodging | $3,819 | 11 | 6.0% |
| Unspecified | $1,345 | 2 | 2.1% |
| Education | $334.87 | 6 | 0.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $40,219 | 108 | $0 (2024) |
| Janssen Biotech, Inc. | $9,950 | 130 | $0 (2024) |
| ABBVIE INC. | $3,555 | 193 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,283 | 87 | $0 (2024) |
| AstraZeneca UK Limited | $783.47 | 1 | $0 (2017) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $693.66 | 33 | $0 (2024) |
| GENZYME CORPORATION | $634.04 | 27 | $0 (2024) |
| Lilly USA, LLC | $608.50 | 31 | $0 (2024) |
| Amgen Inc. | $589.78 | 32 | $0 (2024) |
| Janssen Research & Development, LLC | $561.12 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,587 | 85 | ABBVIE INC. ($404.54) |
| 2023 | $9,359 | 97 | PFIZER INC. ($7,402) |
| 2022 | $6,238 | 81 | PFIZER INC. ($3,994) |
| 2021 | $1,412 | 85 | AbbVie Inc. ($513.46) |
| 2020 | $2,153 | 57 | PFIZER INC. ($847.83) |
| 2019 | $7,890 | 134 | PFIZER INC. ($5,652) |
| 2018 | $8,659 | 153 | PFIZER INC. ($6,567) |
| 2017 | $26,062 | 169 | PFIZER INC. ($15,663) |
All Payment Transactions
861 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: Immunology | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological), BLU-U | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.84 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.00 | General |
| Category: Immunology | ||||||
| 12/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.45 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $37.96 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.05 | General |
| Category: Immunology | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.14 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis who Achieve Complete Clearance on Biologics Brodalumab | AstraZeneca UK Limited | $783.47 | 1 |
| PSOLAR | Janssen Research & Development, LLC | $561.12 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 476 | 756 | $143,260 | $30,316 |
| 2022 | 11 | 517 | 969 | $178,075 | $37,734 |
| 2021 | 14 | 800 | 1,627 | $180,685 | $76,031 |
| 2020 | 14 | 728 | 1,285 | $159,338 | $66,348 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 178 | $34,710 | $10,161 | 29.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 44 | 55 | $20,625 | $6,392 | 31.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 92 | 100 | $30,000 | $4,093 | 13.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 39 | 45 | $22,500 | $2,977 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 23 | $5,175 | $1,903 | 36.8% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 18 | 24 | $7,800 | $1,573 | 20.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 71 | 292 | $14,600 | $1,411 | 9.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,000 | $1,245 | 24.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $2,850 | $561.68 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 230 | $44,850 | $13,085 | 29.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 41 | 61 | $22,875 | $6,887 | 30.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 58 | 64 | $32,000 | $4,820 | 15.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 87 | 108 | $32,400 | $4,202 | 13.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 74 | 409 | $20,450 | $1,987 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 19 | $4,275 | $1,686 | 39.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 15 | 23 | $7,475 | $1,625 | 21.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 11 | $3,850 | $1,092 | 28.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $3,850 | $848.23 | 22.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 22 | $3,300 | $789.34 | 23.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,750 | $711.85 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 180 | 238 | $34,055 | $13,640 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 130 | $26,946 | $12,331 | 45.8% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 59 | 87 | $21,100 | $10,272 | 48.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2021 | 15 | 26 | $14,406 | $7,709 | 53.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 131 | 184 | $22,986 | $7,297 | 31.7% |
About Richard Greene
Richard Greene is a Dermatology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205894169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Greene has received a total of $63,360 in payments from pharmaceutical and medical device companies, with $1,587 received in 2024. These payments were reported across 861 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,700).
As a Medicare-enrolled provider, Greene has provided services to 2,521 Medicare beneficiaries, totaling 4,637 services with total Medicare billing of $210,429. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Boca Raton, FL
- Active Since 05/02/2006
- Last Updated 02/20/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205894169
Products in Payments
- EUCRISA (Drug) $29,045
- CIBINQO (Drug) $11,093
- TREMFYA (Drug) $1,780
- SKYRIZI (Biological) $1,311
- Humira (Biological) $1,215
- Tremfya (Drug) $1,043
- DUPIXENT (Biological) $772.81
- COSENTYX (Biological) $676.72
- RINVOQ (Biological) $618.96
- COSENTYX (Drug) $487.27
- TALTZ (Drug) $472.92
- Enbrel (Biological) $440.52
- ILUMYA (Biological) $430.00
- Sotyktu (Drug) $386.40
- Otezla (Drug) $306.56
- ENSTILAR (Drug) $293.00
- STELARA (Biological) $288.37
- Cimzia (Drug) $247.70
- HUMIRA (Biological) $247.70
- XEOMIN (Biological) $246.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Boca Raton
Dr. Jordana Herschthal, M.d, M.D
Dermatology — Payments: $184,324
Ann Reed, D.o, D.O
Dermatology — Payments: $65,597
Robert Sarro, Md, MD
Dermatology — Payments: $52,032
David Herschthal, Md, MD
Dermatology — Payments: $25,556
Jodi Fiedler, M.d, M.D
Dermatology — Payments: $16,582
Shari Topper, Md, MD
Dermatology — Payments: $13,851